656 related articles for article (PubMed ID: 19161184)
1. Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla.
Park HS; Lee JM; Kim SH; Chang S; Kim SJ; Han JK; Choi BI
J Magn Reson Imaging; 2009 Feb; 29(2):328-35. PubMed ID: 19161184
[TBL] [Abstract][Full Text] [Related]
2. Value of dual contrast liver MRI at 3.0 T in differentiating well-differentiated hepatocellular carcinomas from dysplastic nodules: preliminary results of multivariate analysis.
Yoon MA; Kim SH; Park HS; Lee DH; Lee JY; Han JK; Choi BI
Invest Radiol; 2009 Oct; 44(10):641-9. PubMed ID: 19724237
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity.
Tanabe M; Ito K; Shimizu A; Fujita T; Onoda H; Yamatogi S; Washida Y; Matsunaga N
Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of small (Tonan T; Fujimoto K; Azuma S; Ono N; Matsushita S; Kojiro M; Hayabuchi N
Eur J Radiol; 2007 Oct; 64(1):133-9. PubMed ID: 17408900
[TBL] [Abstract][Full Text] [Related]
5. T2-weighted and T1-weighted dynamic superparamagnetic iron oxide (ferucarbotran) enhanced MRI of hepatocellular carcinoma and hyperplastic nodules.
Chen RC; Lii JM; Chou CT; Chang TA; Chen WT; Li CS; Tu HY
J Formos Med Assoc; 2008 Oct; 107(10):798-805. PubMed ID: 18926947
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: comparison with superparamagnetic iron oxide-enhanced mr imaging.
Kim YK; Kim CS; Kwak HS; Lee JM
J Magn Reson Imaging; 2004 Nov; 20(5):826-37. PubMed ID: 15503325
[TBL] [Abstract][Full Text] [Related]
7. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT.
Kim YK; Kwak HS; Kim CS; Chung GH; Han YM; Lee JM
Radiology; 2006 Feb; 238(2):531-41. PubMed ID: 16371577
[TBL] [Abstract][Full Text] [Related]
9. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
[TBL] [Abstract][Full Text] [Related]
10. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
11. Detection of hepatocellular carcinoma with ferucarbotran (resovist)-enhanced breath-hold MR imaging: feasibility of 10 minute-delayed images.
Saito K; Shindo H; Ozuki T; Ishikawa A; Kotake F; Shimazaki Y; Abe K
Magn Reson Med Sci; 2008; 7(3):123-30. PubMed ID: 18827455
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma in cirrhotic liver: double-contrast-enhanced, high-resolution 3.0T-MR imaging with pathologic correlation.
Yoo HJ; Lee JM; Lee MW; Kim SJ; Lee JY; Han JK; Choi BI
Invest Radiol; 2008 Jul; 43(7):538-46. PubMed ID: 18580337
[TBL] [Abstract][Full Text] [Related]
13. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
[TBL] [Abstract][Full Text] [Related]
14. Effect of superparamagnetic iron oxide on tumor-to-liver contrast at T2*-weighted gradient-echo MRI: comparison between 3.0T and 1.5T MR systems.
Kim T; Murakami T; Hori M; Onishi H; Tomoda K; Nakamura H
J Magn Reson Imaging; 2009 Mar; 29(3):595-600. PubMed ID: 19243054
[TBL] [Abstract][Full Text] [Related]
15. SPIO-enhanced MRI findings of well-differentiated hepatocellular carcinomas: correlation with MDCT findings.
Kim SH; Lee WJ; Lim HK; Park CK
Korean J Radiol; 2009; 10(2):112-20. PubMed ID: 19270856
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver.
Pauleit D; Textor J; Bachmann R; Conrad R; Flacke S; Layer G; Kreft B; Schild H
Radiology; 2002 Jan; 222(1):73-80. PubMed ID: 11756708
[TBL] [Abstract][Full Text] [Related]
17. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times.
Kim JH; Kim MJ; Suh SH; Chung JJ; Yoo HS; Lee JT
J Magn Reson Imaging; 2002 May; 15(5):573-83. PubMed ID: 11997899
[TBL] [Abstract][Full Text] [Related]
18. Gadoxetate Disodium-Enhanced MRI to Differentiate Dysplastic Nodules and Grade of Hepatocellular Carcinoma: Correlation With Histopathology.
Channual S; Tan N; Siripongsakun S; Lassman C; Lu DS; Raman SS
AJR Am J Roentgenol; 2015 Sep; 205(3):546-53. PubMed ID: 26295640
[TBL] [Abstract][Full Text] [Related]
19. Nodule-in-nodule appearance of hepatocellular carcinomas: comparison of gadolinium-enhanced and ferumoxides-enhanced magnetic resonance imaging.
Goshima S; Kanematsu M; Matsuo M; Kondo H; Kato H; Yokoyama R; Hoshi H; Moriyama N
J Magn Reson Imaging; 2004 Aug; 20(2):250-5. PubMed ID: 15269950
[TBL] [Abstract][Full Text] [Related]
20. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
